Gum Disease and Heart: Association,Inflammation, and What Actually Matters
- Saneka Chakravarty, MD, FACC
- Jun 29
- 4 min read
The connection between periodontal (gum) disease and cardiovascular disease (CVD) is one of the most discussed and misunderstood topics in prevention.
Here is the precise, evidence-based takeaway:
Gum disease is linked to heart disease, but treating it has not been proven to prevent heart attacks or strokes.
1. Association # Causation
The American Heart Association is clear:
. There is no definitive causal relationship
. But there is a strong, independent association supported by biology
Even after adjusting for shared risk factors (smoking, diabetes, obesity), the relationship persists.
A large 2023 meta-analysis (>4 million individuals) found:
· Cardiovascular events 24%
. Coronary heart disease 20%
· Stroke 26%
. Cardiac death 42%
This is not trivial. It suggests periodontal disease behaves like a systemic risk modifier, not just a bystander.
2. Why the Mouth Can Affect the Heart
The biology is coherent and clinically plausible.
Direct vascular effects
Oral bacteria (e.g., Porphyromonas gingivalis) enter the bloodstream
Detected inside atherosclerotic plaques
Invade endothelial cells -> endothelial dysfunction
Indirect systemic effects
Chronic inflammation:
CRP 1
IL-61
TNF-a t
Platelet activation -> pro-thrombotic state
Immune cross-reactivity damaging vascular tissue
Oral microbiome imbalance amplifying systemic inflammation
This is why periodontal disease is increasingly viewed as a chronic inflammatory
condition with vascular consequences.
3. Treatment: Clear Biomarker Gains, No Proven Event Reduction
Here's where the nuance matters.
What improves with periodontal therapy:
. CRP J~0.69 mg/L (clinically meaningful)
. IL-6, TNF-a J
. Endothelial function (FMD) 1
. Carotid artery thickness progression
· Lipids and glucose metabolism improve (especially in diabetes)
These changes are in the same range as many lifestyle interventions.
What has NOT been shown:
· Reduction in:
Myocardial infarction
Stroke
Cardiovascular death
Trials like PAVE and PREMIERS show trends but no statistical confirmation. It is likely
that the trials were too small( 280-300 participants each) and too short (12 months) to show
any real difference.
The American Heart Association summarizes it succinctly:
Periodontal disease contributes to inflammation, but there is no direct evidence that treatment prevents cardiovascular events.
4. The Hidden Detail Most People Miss
Periodontal treatment has a biphasic inflammatory response:
Short term (24-48 hrs): Temporary spike in inflammation (bacteremia effect)
Long term (months): Sustained reduction below baseline
Clinically relevant insight: Staged or less aggressive treatment may be preferable in high-risk cardiac patients
5. Why the Evidence Gap Exists
The disconnect between improved biomarkers and lack of event reduction likely reflects:
. Trials that are too small
. Follow-up periods that are too short
. Effects that are real but modest
. Difficulty isolating periodontal disease from other inflammatory exposures
In other words: the biology is convincing, but the outcomes science hasn't caught up, as often seen with primary prevention trials.
6. Practical Prevention Takeaways
Think of periodontal care as part of a broader cardiometabolic strategy:
It IS:
A way to reduce systemic inflammation
A contributor to vascular health optimization
Particularly relevant in:
Diabetes
High CRP / inflammatory states
Established atherosclerosis
It is NOT:
A substitute for:
Statins
Blood pressure control
Lifestyle intervention
Bottom Line
Gum disease is independently associated with cardiovascular risk
Treating it improves inflammation and vascular function
But it has not been proven to reduce heart attacks or strokes
This places periodontal therapy in a critical but often misclassified category:
"Adjunctive risk optimization": not "proven event reduction."
FAQ
Should I ecreen heart patiente for gum disea se?
Yes, especially if they have diabeles or elevated inflammatory markers.
ls this just correlation from shared risk factors?
No. The association persists even after adjustment for most likely variatles, suggesting an
independent effect, although there is no way to completely rule out an unknown variable.
Doee treating gum disease help overall health?
Yes, partioularly for inflammation and metabalic contral.
Should thle change clinical practice?
It should expand it. Oral heatth belongs in cardlovaecular prevention conversations.
References
1. Periodontal Disease and Atherosclerotic Cardiovasoular Disease: A Scientific Statement From the American Heart Association. Tran AH, Zaidi AH, Balger AF, et al. Circulation. 2025 ;. doi:10.1161/CIR.0000000000001390.
2. Periodontal Disease and Subsequent Risk of Cardiovascular Outcome and Al-Cause Mortality: AMeta-Analysis of Prospective Studies. Guo X, Li X, Liao C, Feng X, He T. PloS One. 2023;18(9)e0290545. doi:10.1371/journal.pone.0290545.
3. Mechanisms Underlying the Association Between Periodontiis and Atherosderotic Disease. Schenkein HA, Papapanou PN, Genco R, Sanz M. Periodontology 2000. 2020;83(1):90-106. doi:10.1111/prdl12304.
4. Periodontal Diseases and Association With Atherosclerotic Disease. Herrera D, Molina A, Buhlin K, Klinge B. Periodontology 2000. 2020;83(1):66-89. doi:10.1111/prd.12302.
5. Periodontal Disease and Atherosderotic Cardiovascular Disease: A Sciertific
Staterent From the American Heart Association. Tran AH, Zaidi AH, Bolger AF, et al.
Circulation. 2025 ;_ doi:10.1161/CIR.0000000000001390.
6. Periodontal Therapy for Primary or Secondary Prevention of Cardiovascular Disease in People With Periodontitis. Ye Z, Cao Y, Miao C, et al. The Cochrane Database of Systematic Reviews. 2022;10:CD009197. doi:10.1002/14651858.CD009197.pub5.
7. Treatment of Periodontitis and C-Readive Protein: A Systematic Review and Mela- Analysis of Randomized Cinical Trials. Luthra S, Orlandi M, Hussain SB, et al. Joumnsl of Clinical Periodontalogy. 2023;50(1):45-60. doi:10.1111/jcpe.13709.
8. Effect of Periodontal Treatment on Reducing Chronic Inflammation in Systemically Healthy Patients With Periodontal Disease. Matsuda S, Shintari T, Miyagawa T, et al. The American Journal of Medicine. 2024; 137(3):273-279.e2.
doi: 10.1016/j.amjmed.2023.11.001.
9. Serum C-Reacive Protein and Periodontifs: A Systematic Review and Meta-Analysis. Mchdo V, Botelho J, Escalda C, et al. Frontiers in Immunology. 2021;12:706432. doi: 10.3389/fimmu.2021.706432.
10. Treatment of Periodontitis and Endothelial Function Tonetti MS, D'Aiuto F, Nibali L, et al. The New England Joumal of Medicine. 2007;356(9):911-20. doi: 10.1058/NEJMoa063186.
11. Temporal Dynarics of Early Inflammatory Markers After Professional Dental Cleaning AMeta-Analysis and Spline-Based Meta-Regression of TNF-a, IL-16, IL-6, and (Hs)CRP. Cardiscian M, Di Nicolantonio S, Altamura S, et al. Frontiers in Immunology. 2025;16:1634622. doi:10.3389/fimmu.2025.1634622.
12. Impact af the Treatment of Periodontitis on Systemic Health and Quality of Life: A. Systematic Review. Orlandi M, Muriaz Aguilera E, Marletta D, et al. Joumal of Clinical Periodontology. 2022;49 Suppl 24:314-327. doi: 10.1111/jepe.13554.
13. The Effect of Periodontal Treatments on Endothelial Function in Degrees of
Periodontitis Patienits: A Systematic Review and Meta-Analysis. Lyu J, Zhang Y, Zhou R, et al. PloS One. 2024;19(9)ce0308793. doi:10.1371/journal.pone.0308793.
14. Periodontitis Treatment and Progression of Carotid Intima-Media Thickness: A
Randomrized Trial. Orlandi M, Masi S, Lucenteforte E, et al. European Heart Joumal.
2025;ehaf555. doi:10.1093/eurheartj/cha1555.
15. Impact of Nonsurgical Periodontal Treatment on Arterial Stiffness Outcomes Related to Endothelial Dysfunction: A Systematic Review and Meta-Analysis. Polizzi A, Nibali L, Tartaglia GM, Isola G. Joumal of Periodontalogy. 2025;96(4):330-345.
doi: 10.1002/JPER.24-0422.
Comments